Skip to main content
. Author manuscript; available in PMC: 2015 Aug 6.
Published in final edited form as: J Nucl Med. 2015 Jun 25;56(8):1223–1228. doi: 10.2967/jnumed.115.158717

Table 4.

Results of Univariate and Multivariate Cox Regression Analysis for Predictors of Survival in Pretreatment Glioma Patients (n = 38)

Univatiate
Survival
TTP
Hazard P Hazard P
Age 1.73   0.005 1.73   0.004
Gender 1.77   0.144 1.80   0.131
KPS 0.63   0.019 0.67   0.028
HV 2.30 <0.001 2.07 <0.001
ID-HV 2.69 <0.001 2.45 <0.001
TBmax 2.51 <0.001 2.34 <0.001
ID-TBmax 2.41 <0.001 2.31 <0.001
Resection* 1.21   0.604 1.16   0.664
Multivariate
Survival (0.390)
TTP (0.466)
Hazard P Hazard P
Age 1.26 0.421 1.44   0.158
Gender 1.77   0.525 1.43   0.440
KPS 0.78   0.324 0.88   0.554
TBmax 2.37 <0.001 2.31 <0.001
Resection 0.76   0.516 0.75   0.463
Survival (0.394) TTP (0.485)
Hazard P Hazard P
Age 1.22   0.483 1.38   0.210
Gender 1.23   0.676 1.31   0.559
KPS 0.75   0.244 0.82   0.378
ID-TBmax 2.30 <0.001 2.30 <0.001
Resection 0.81   0.616 0.77   0.519
*

Resection is dichotomized as biopsy or other (gross/sub-total resection).

The coefficient of determination (R2) is given for each table.

Univariate analysis of hypoxia and clinical variables shows the hazard ratio with P values associated with survival and TTP at 2 years. After adjusting for clinical variables using a multivariate model, greater tumor TBmax was still associated with shorter survival and TTP. Multivariate results for HV and ID-HV appear in supplemental materials.